Showing results (11-20 of 768) with videos related to
Sort By:
Pageof 77
Biochemical Pharmacology|July 15, 1987
In vitro inhibition of phenolsulphotransferase by food and drink constituentsC Gibb, V Glover, M SandlerJournal of Neurochemistry|August 1, 1985
Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam bindingA Clow, V Glover, M SandlerBiochemical Pharmacology|May 15, 1982
Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenolG Rein, V Glover, M SandlerLife Sciences|June 2, 1986
Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissuesI Armando, V Glover, M SandlerJournal of Neural Transmission. Supplementum|January 1, 1993
Effects of dopaminergic drugs on superoxide dismutase: implications for senescenceV Glover, A Clow, M SandlerJournal of Neural Transmission. Supplementum|January 1, 1986
The role of MAO in MPTP toxicity--a reviewV Glover, C Gibb, M SandlerNeuroscience Letters|February 28, 1986
Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissuesV Glover, C Gibb, M SandlerJournal of Neurochemistry|January 1, 1984
Characterization of human brain phenolsulphotransferaseG Rein, V Glover, M SandlerEuropean Journal of Pharmacology|December 28, 1999
The influence of isatin on guanylyl cyclase of rat heart membranesA Medvedev, M Sandler, V GloverClinica Chimica Acta; International Journal of Clinical Chemistry|April 9, 1981
Sulphate conjugation of biologically active monoamines and their metabolites by human platelet phenolsulphotransferaseG Rein, V Glover, M SandlerPageof 77